Effects of sodium-glucose co-transporter-2 (SGLT2) inhibitors on non-alcoholic fatty liver disease/non-alcoholic steatohepatitis: Ex quo et quo vadimus?
作者信息
Katsiki Niki, Perakakis Nikolaos, Mantzoros Christos
机构信息
Beth-Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States of America.
Beth-Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States of America.
出版信息
Metabolism. 2019 Sep;98:iii-ix. doi: 10.1016/j.metabol.2019.07.009. Epub 2019 Jul 11.
Abstract
摘要
Zotero 插件